Ilyang PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Ilyang PharmaceuticalLtd has a total shareholder equity of ₩264.7B and total debt of ₩90.8B, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are ₩473.8B and ₩209.1B respectively. Ilyang PharmaceuticalLtd's EBIT is ₩23.2B making its interest coverage ratio 7.1. It has cash and short-term investments of ₩23.6B.
Key information
34.3%
Debt to equity ratio
₩90.76b
Debt
Interest coverage ratio | 7.1x |
Cash | ₩23.65b |
Equity | ₩264.70b |
Total liabilities | ₩209.10b |
Total assets | ₩473.80b |
Recent financial health updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24Recent updates
Is Ilyang PharmaceuticalLtd (KRX:007570) A Risky Investment?
Apr 04Should You Be Adding Ilyang PharmaceuticalLtd (KRX:007570) To Your Watchlist Today?
Mar 14Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Shares May Have Slumped 36% But Getting In Cheap Is Still Unlikely
Mar 14Declining Stock and Decent Financials: Is The Market Wrong About Ilyang Pharmaceutical Co.,Ltd (KRX:007570)?
Feb 22Did Business Growth Power Ilyang PharmaceuticalLtd's (KRX:007570) Share Price Gain of 159%?
Feb 01Is Ilyang Pharmaceutical Co.,Ltd's (KRX:007570) Shareholder Ownership Skewed Towards Insiders?
Jan 11Here's Why Ilyang PharmaceuticalLtd (KRX:007570) Can Manage Its Debt Responsibly
Dec 24A Look At The Intrinsic Value Of Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
Dec 06Ilyang Pharmaceutical Co.,Ltd (KRX:007570) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 18Financial Position Analysis
Short Term Liabilities: A007570's short term assets (₩167.3B) do not cover its short term liabilities (₩186.2B).
Long Term Liabilities: A007570's short term assets (₩167.3B) exceed its long term liabilities (₩22.9B).
Debt to Equity History and Analysis
Debt Level: A007570's net debt to equity ratio (25.4%) is considered satisfactory.
Reducing Debt: A007570's debt to equity ratio has reduced from 63.8% to 34.3% over the past 5 years.
Debt Coverage: A007570's debt is well covered by operating cash flow (30.1%).
Interest Coverage: A007570's interest payments on its debt are well covered by EBIT (7.1x coverage).